Exact Mass: 343.3239

Exact Mass Matches: 343.3239

Found 56 metabolites which its exact mass value is equals to given mass value 343.3239, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

N-Acetylsphinganine

N-(1,3-Dihydroxyoctadecan-2-yl)ethanimidate

C20H41NO3 (343.3086)


   

(+)-17-Oxocycloprotobuxine

(+)-17-Oxocycloprotobuxine

C23H37NO (343.2875)


   
   

(+)-3-deoxybuxandonine

(+)-3-deoxybuxandonine

C24H41N (343.3239)


   

3beta-Dimethylamino-20-oxo-pregnen-5|3beta-Dimethylamino-5-pregnen-20-on|Dimethylholaphyllamin|Methyl-holaphyllin|Methylholaphyllin

3beta-Dimethylamino-20-oxo-pregnen-5|3beta-Dimethylamino-5-pregnen-20-on|Dimethylholaphyllamin|Methyl-holaphyllin|Methylholaphyllin

C23H37NO (343.2875)


   

(20R)-3beta-Dimethylamino-18,20-oxido-pregnen-5|(20R)-N,N-Dimethyl-3beta-amino-18,20-oxido-Delta5-pregnen|3beta-Dimethylamino-18,20beta-oxido-pregn-5-en

(20R)-3beta-Dimethylamino-18,20-oxido-pregnen-5|(20R)-N,N-Dimethyl-3beta-amino-18,20-oxido-Delta5-pregnen|3beta-Dimethylamino-18,20beta-oxido-pregn-5-en

C23H37NO (343.2875)


   

Dimethylholaphyllamine

Dimethylholaphyllamine

C23H37NO (343.2875)


   

(9Z,14Z)-octadeca-9,14-dien-12-ynoic acid piperidine

(9Z,14Z)-octadeca-9,14-dien-12-ynoic acid piperidine

C23H37NO (343.2875)


   

(E)-salignone

(E)-salignone

C23H37NO (343.2875)


   

4-Dihydrofuntumafrine C

4-Dihydrofuntumafrine C

C23H37NO (343.2875)


   

C2 Dihydroceramide

C2 Dihydroceramide

C20H41NO3 (343.3086)


   

(2E,9Z)-octadeca-2,9-dien-12-ynoic acid piperidine

(2E,9Z)-octadeca-2,9-dien-12-ynoic acid piperidine

C23H37NO (343.2875)


   

(3alpha,5alpha)-3-Aminopregn-16-en-20-one

(3alpha,5alpha)-3-Aminopregn-16-en-20-one

C23H37NO (343.2875)


   

(20S)-20-(methylamino)-3beta-methoxypregn-5,16-diene|salignamine

(20S)-20-(methylamino)-3beta-methoxypregn-5,16-diene|salignamine

C23H37NO (343.2875)


   

Arachidonoyl Cyclopropylamide

N-cyclopropyl-5Z,8Z,11Z,14Z-eicosatetraenamide

C23H37NO (343.2875)


   

C15DEA

C15DEA

C20H41NO3 (343.3086)


Literature spectrum; CONFIDENCE Tentative identification: isomers possible (Level 3); May be an alkyl homologue; Digitised from figure: approximate intensities

   

Lauramidopropylbetaine

Lauramidopropylbetaine

[C19H39N2O3]+ (343.2961)


CONFIDENCE standard compound; INTERNAL_ID 2849

   

Lauramidopropyl betaine

Lauramidopropyl betaine

[C19H39N2O3]+ (343.2961)


CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 15

   

Dihydroceramide C2

Dihydroceramide C2

C20H41NO3 (343.3086)


   

Behenic acid(d3)

Docosanoic acid(d3)

C22H41D3O2 (343.3529)


   

SPB 21:0;O2

iso (19-methyl-d20:0) sphinganine

C21H45NO2 (343.345)


   

cedefingol

cedefingol

C20H41NO3 (343.3086)


C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor

   

N,N-Bis(2-hydroxyethyl)hexadecanamide

N,N-bis(2-hydroxyethyl)hexadecan-1-amide

C20H41NO3 (343.3086)


   

Octadecanamide,12-hydroxy-N-(2-hydroxyethyl)-

Octadecanamide,12-hydroxy-N-(2-hydroxyethyl)-

C20H41NO3 (343.3086)


   

Ethanolamine oleate

monoethanolamine oleate

C20H41NO3 (343.3086)


C - Cardiovascular system > C05 - Vasoprotectives > C05B - Antivaricose therapy > C05BB - Sclerosing agents for local injection D019999 - Pharmaceutical Solutions > D012597 - Sclerosing Solutions C78275 - Agent Affecting Blood or Body Fluid D002317 - Cardiovascular Agents

   

N-Acetylsphinganine

N-[(2S,3R)-1,3-dihydroxyoctadecan-2-yl]acetamide

C20H41NO3 (343.3086)


A dihydroceramide in which the ceramide acyl group is specified as acetyl.

   

3-(Dodecanoylamino)propyl(carboxymethyl)dimethylammonium

3-(Dodecanoylamino)propyl(carboxymethyl)dimethylammonium

C19H39N2O3+ (343.2961)


   

2-Aminohenicosane-1,3-diol

2-Aminohenicosane-1,3-diol

C21H45NO2 (343.345)


   

N-(1,3-dihydroxyhexadecan-2-yl)butanamide

N-(1,3-dihydroxyhexadecan-2-yl)butanamide

C20H41NO3 (343.3086)


   

N-(1,3-dihydroxyoctan-2-yl)dodecanamide

N-(1,3-dihydroxyoctan-2-yl)dodecanamide

C20H41NO3 (343.3086)


   

N-(1,3-dihydroxypentadecan-2-yl)pentanamide

N-(1,3-dihydroxypentadecan-2-yl)pentanamide

C20H41NO3 (343.3086)


   

N-(1,3-dihydroxyundecan-2-yl)nonanamide

N-(1,3-dihydroxyundecan-2-yl)nonanamide

C20H41NO3 (343.3086)


   

N-(1,3-dihydroxyheptadecan-2-yl)propanamide

N-(1,3-dihydroxyheptadecan-2-yl)propanamide

C20H41NO3 (343.3086)


   

N-(1,3-dihydroxynonan-2-yl)undecanamide

N-(1,3-dihydroxynonan-2-yl)undecanamide

C20H41NO3 (343.3086)


   

N-(1,3-dihydroxytridecan-2-yl)heptanamide

N-(1,3-dihydroxytridecan-2-yl)heptanamide

C20H41NO3 (343.3086)


   

N-(1,3-dihydroxytetradecan-2-yl)hexanamide

N-(1,3-dihydroxytetradecan-2-yl)hexanamide

C20H41NO3 (343.3086)


   

N-(1,3-dihydroxydodecan-2-yl)octanamide

N-(1,3-dihydroxydodecan-2-yl)octanamide

C20H41NO3 (343.3086)


   

N-(1,3-dihydroxydecan-2-yl)decanamide

N-(1,3-dihydroxydecan-2-yl)decanamide

C20H41NO3 (343.3086)


   

Sphingosine (t20:1)

SPH(t20:1)

C20H41NO3 (343.3086)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

[(1s)-1-[(1s,3r,8r,11r,12s,15s,16r)-12,16-dimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl]ethyl]dimethylamine

[(1s)-1-[(1s,3r,8r,11r,12s,15s,16r)-12,16-dimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl]ethyl]dimethylamine

C24H41N (343.3239)


   

1-(piperidin-1-yl)octadeca-9,14-dien-12-yn-1-one

1-(piperidin-1-yl)octadeca-9,14-dien-12-yn-1-one

C23H37NO (343.2875)


   

1-(piperidin-1-yl)octadeca-2,9-dien-12-yn-1-one

1-(piperidin-1-yl)octadeca-2,9-dien-12-yn-1-one

C23H37NO (343.2875)


   

(1e,3as,3br,5as,7s,9as,9bs,11as)-7-(dimethylamino)-1-ethylidene-9a,11a-dimethyl-dodecahydro-3h-cyclopenta[a]phenanthren-2-one

(1e,3as,3br,5as,7s,9as,9bs,11as)-7-(dimethylamino)-1-ethylidene-9a,11a-dimethyl-dodecahydro-3h-cyclopenta[a]phenanthren-2-one

C23H37NO (343.2875)


   

7,7,12,16-tetramethyl-6-(methylamino)pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-one

7,7,12,16-tetramethyl-6-(methylamino)pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-one

C23H37NO (343.2875)


   

(1-{7-methoxy-9a,11a-dimethyl-3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}ethyl)(methyl)amine

(1-{7-methoxy-9a,11a-dimethyl-3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}ethyl)(methyl)amine

C23H37NO (343.2875)


   

(1-{12,16-dimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl}ethyl)dimethylamine

(1-{12,16-dimethylpentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl}ethyl)dimethylamine

C24H41N (343.3239)


   

1-[(1r,3as,3bs,7s,9ar,9br,11ar)-7-(dimethylamino)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]ethanone

1-[(1r,3as,3bs,7s,9ar,9br,11ar)-7-(dimethylamino)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]ethanone

C23H37NO (343.2875)


   

(1s,3r,6s,8r,11s,12s,16s)-7,7,12,16-tetramethyl-6-(methylamino)pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-one

(1s,3r,6s,8r,11s,12s,16s)-7,7,12,16-tetramethyl-6-(methylamino)pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-one

C23H37NO (343.2875)


   

[(1s)-1-[(3as,3br,7s,9ar,9bs,11as)-7-methoxy-9a,11a-dimethyl-3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]ethyl](methyl)amine

[(1s)-1-[(3as,3br,7s,9ar,9bs,11as)-7-methoxy-9a,11a-dimethyl-3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]ethyl](methyl)amine

C23H37NO (343.2875)


   

n-[(2s,3r)-1,3-dihydroxyoctadecan-2-yl]ethanimidic acid

n-[(2s,3r)-1,3-dihydroxyoctadecan-2-yl]ethanimidic acid

C20H41NO3 (343.3086)


   

n-(1,3-dihydroxyoctadecan-2-yl)ethanimidic acid

n-(1,3-dihydroxyoctadecan-2-yl)ethanimidic acid

C20H41NO3 (343.3086)


   

1-[7-(dimethylamino)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]ethanone

1-[7-(dimethylamino)-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]ethanone

C23H37NO (343.2875)


   

(2e,9z)-1-(piperidin-1-yl)octadeca-2,9-dien-12-yn-1-one

(2e,9z)-1-(piperidin-1-yl)octadeca-2,9-dien-12-yn-1-one

C23H37NO (343.2875)


   

(9z,14z)-1-(piperidin-1-yl)octadeca-9,14-dien-12-yn-1-one

(9z,14z)-1-(piperidin-1-yl)octadeca-9,14-dien-12-yn-1-one

C23H37NO (343.2875)


   

(2s,6s,9as)-6-{[(7s,8as)-1,7-dimethyl-3,4,6,7,8,8a-hexahydro-2h-quinolin-5-yl]methyl}-2,4-dimethyl-1,2,3,6,7,8,9,9a-octahydro-5λ⁵-quinolizin-5-ylium

(2s,6s,9as)-6-{[(7s,8as)-1,7-dimethyl-3,4,6,7,8,8a-hexahydro-2h-quinolin-5-yl]methyl}-2,4-dimethyl-1,2,3,6,7,8,9,9a-octahydro-5λ⁵-quinolizin-5-ylium

[C23H39N2]+ (343.3113)


   

(1z,3as,3br,5as,7s,9as,9bs,11as)-7-(dimethylamino)-1-ethylidene-9a,11a-dimethyl-dodecahydro-3h-cyclopenta[a]phenanthren-2-one

(1z,3as,3br,5as,7s,9as,9bs,11as)-7-(dimethylamino)-1-ethylidene-9a,11a-dimethyl-dodecahydro-3h-cyclopenta[a]phenanthren-2-one

C23H37NO (343.2875)